CD38 and COVID-19: While both B memory cell populations (non–class‐switched and class‐switched) did not differ between COVID‐19 convalescent patients and healthy control subjects, numbers of early B cells characterized as CD19+IgM+CD38+ transitional B cells as well as plasmablasts were higher in convalescents as compared to healthy controls.